When the Néré inspires a strengthened barrier effect

Discover the movie about our traceable and sustainable supply chain of Néré in Burkina Faso, raw material of the active ingredient NERENYL®.

Play the movie


The interactive solution to harmful urban pollution

MITOKINYL® protects fragile skin against urban stresses and is recommended in all anti-pollution facial and body skincare products.


Be part of our LinkedIN and Viadeo networks!

Follow in real time our latest news and job opportunities on our Company pages!

linkedIn viadeo

SILAB LinkedIN and Viadeo


La régénération matricielle anti-âge

For a visibly younger face with redefined contours, ETERNALINE® is recommended for all anti-aging regenerative day/night skin care products.



Quand le Néré inspire un effet barrière renforcé

Strengthened skin barrier, moisturized skin, restored healthy glow, NERENYL® is recommended for all face and body care products.



It’s the largest breakthrough in biology of the past 5 years...
Discover our movie about epigenetics and EPIGENOMYL®,
who protects the epigenome and its components to reactivate the skin’s youth.

Play the movie

Our products


The excellence of a natural, protective and lifting film
More information »


The interactive solution to harmful urban pollution
More information »


Anti-aging matrix regeneration
More information » Discover all the SILAB products

Meet us

New York SCC

Dates: from Tuesday 10 May 2016
through Wednesday 11 May 2016

FCE Cosmetique

Dates: from Tuesday 10 May 2016
through Thursday 12 May 2016

in-cosmetics Korea

Dates: from Wednesday 06 July 2016
through Thursday 07 July 2016
See all the events

We hire

R&D Assistant

Reference of the offer: 2016-8-R&D-AST
Learn more »

Quality Assurance Project Leader

Reference of the offer: 2016-5-Q-AQ
Learn more »

Customer Project Leader

Reference of the offer: 2016-1-CIAL-CPC
Learn more » Consult all the offers


Inserm, Inserm Transfert and SILTISS have signed a license agreement in the field of natural-origin biomaterials

SILTISS, a spin-off of SILAB, is a new player in the tissue regeneration sector, based on work developed by two Inserm teams in Paris1 and Bordeaux2.

SILTISS, the new subsidiary of the SILAB Group, founded in January 2016, has acquired exclusive rights to use a tissue engineering technology developed by Inserm.

On April 19, 2016, at the company's headquarters in Brive, an exclusive license agreement was signed for a portfolio of four Inserm patents, between Pascale Augé, Chairman of the Board of Directors, Inserm Transfert, and Jean Paufique, Chairman and Founder of SILTISS.

Read more »
published on Tuesday 26 April 2016